Biomarkers of eosinophilic inflammation in asthma

References

• Farahi N, Singh NR, Heard S, et al. Use of 111-indium-labeled autologous eosinophils to establish the in vivo kinetics of human eosinophils in healthy subjects. Blood 2012;120(19):4068-71
   Google Scholar
• Rosenberg HF, Dyer KD, Foster PS. Eosinophils: changing perspectives in health and disease. Nat Rev Immunol 2013;13(1):9-22
   Google Scholar
• Klion AD, Nutman TB. The role of eosinophils in host defense against helminth parasites. J Allergy Clin Immunol 2004;113(1):30-7
   PubMed Web of Science ®Google Scholar
• Fabre V, Beiting DP, Bliss SK, et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol 2009:182(3):1577-83
   Google Scholar
• Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med 2012;18(5):716-25
   PubMed Web of Science ®Google Scholar
• Bochner BS, Busse WW. Allergy and asthma. J Allergy Clin Immunol 2005;115(5):953-9
   PubMedGoogle Scholar
• Minshall EM, Leung DY, Martin RJ, et al. Eosinophil-associated TGF-beta1 mRNA expression and airways fibrosis in bronchial asthma. Am J Respir Cell Mol Biol 1997;17(3):326-33
   PubMed Web of Science ®Google Scholar
• Flood-Page P, Menzies-Gow A, Phipps S, et al. Anti-IL-5 treatment reduces deposition of ECM proteins in the bronchial subepithelial basement membrane of mild atopic asthmatics. J Clin Invest 2003;112(7):1029-36
   PubMed Web of Science ®Google Scholar
• Barnes PJ. Reactive oxygen species and airway inflammation. Free Radic Biol Med 1990;9(3):235-43
   PubMed Web of Science ®Google Scholar
• Bousquet J, Chanez P, Lacoste JY, et al. Eosinophilic inflammation in asthma. N Engl J Med 1990;323(15):1033-9
   PubMed Web of Science ®Google Scholar
• Broide D, Gleich G, Cuomo A, et al. Evidence of ongoing mast cell and eosinophil degranulation in symptomatic asthma airway. J Allergy Clin Immunol 1991;88(4):637-48
   PubMed Web of Science ®Google Scholar
• Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med 2012;366(6):539-51
   PubMed Web of Science ®Google Scholar
• Lim S, Jatakanon A, John M, et al. Effect of inhaled budesonide on lung function and airway inflammation. Assessment by various inflammatory markers in mild asthma. Am J Respir Crit Care Med 1999;159(1):22-30
   PubMed Web of Science ®Google Scholar
• Castro M, Mathur S, Hargreave F, et al. Reslizumab for poorly controlled, eosinophilic asthma: a randomized, placebo-controlled study. Am J Respir Crit Care Med 2011;184(10):1125-32
   PubMed Web of Science ®Google Scholar
• Wenzel S, Ford L, Pearlman D, et al. Dupilumab in persistent asthma with elevated eosinophil levels. N Engl J Med 2013;368:2455-66
   PubMed Web of Science ®Google Scholar
• Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011;365(12):1088-98
   PubMed Web of Science ®Google Scholar
• Nair P, Pizzichini MM, Kjarsgaard M, et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med 2009;360(10):985-93
   PubMed Web of Science ®Google Scholar
• Busse W, Corren J, Lanier BQ, et al. Omalizumab, anti-IgE recombinant humanized monoclonal antibody, for the treatment of severe allergic asthma. J Allergy Clin Immunol 2001;108(2):184-90
   PubMed Web of Science ®Google Scholar
• Flood-Page PT, Menzies-Gow AN, Kay AB, Robinson DS. Eosinophil's role remains uncertain as anti-interleukin-5 only partially depletes numbers in asthmatic airway. Am J Respir Crit Care Med 2003;167(2):199-204
   PubMed Web of Science ®Google Scholar
• Haldar P, Brightling CE, Hargadon B, et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med 2009;360:973-84
   PubMed Web of Science ®Google Scholar
• Leckie MJ, Brinke AT, Khan J, et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet 2000;356(9248):2144-8
   PubMed Web of Science ®Google Scholar
• Lim S, Jatakanon A, Meah S, et al. Relationship between exhaled nitric oxide and mucosal eosinophilic inflammation in mild to moderately severe asthma. Thorax 2000;55(3):184-8
   PubMedGoogle Scholar
• Crimi E, Spanevello A, Neri M, et al. Dissociation between airway inflammation and airway hyperresponsiveness in allergic asthma. Am J Respir Crit Care Med 1998;157(1):4-9
   PubMed Web of Science ®Google Scholar
• Horváth I, Hunt J, Barnes PJ, et al. Exhaled breath condensate: methodological recommendations and unresolved questions. Eur Respir J 2005;26(3):523-48
   PubMed Web of Science ®Google Scholar
• Tufvesson E, Bjermer L. Methodological improvements for measuring eicosanoids and cytokines in exhaled breath condensate. Respir Med 2006;100(1):34-8
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Wenzel S, Brown R, et al. Asthma outcomes: biomarkers. J Allergy Clin Immunol 2012;129(Suppl 3):S9-23
   PubMed Web of Science ®Google Scholar
• Fireman E, Shtark M, Priel IE, et al. Hydrogen peroxide in exhaled breath condensate (EBC) vs eosinophil count in induced sputum (IS) in parenchymal vs airways lung diseases. Inflammation 2007;30(1-2):44-51
   Google Scholar
• Dweik RA, Boggs PB, Erzurum SC, et al. American Thoracic Society Committee on Interpretation of Exhaled Nitric Oxide Levels (FENO) for Clinical Applications. An official ATS clinical practice guideline: interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 2011;184:602-15
   PubMed Web of Science ®Google Scholar
• McNicholl DM, Stevenson M, McGarvey LP, Heaney LG. The utility of fractional exhaled nitric oxide suppression in the identification of nonadherence in difficult asthma. Am J Respir Crit Care Med 2012;186(11):1102-8
   PubMed Web of Science ®Google Scholar
• Smith AD, Cowan JO, Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 2005;352(21):2163-73
   PubMed Web of Science ®Google Scholar
• Shaw DE, Berry MA, Thomas M, et al. The use of exhaled nitric oxide to guide asthma management: a randomized controlled trial. Am J Respir Crit Care Med 2007;176(3):231-7
   PubMed Web of Science ®Google Scholar
• Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment for inner-city adolescents and young adults: a randomised controlled trial. Lancet 2008;372(9643):1065-72
   PubMed Web of Science ®Google Scholar
• Petsky HL, Cates CJ, Lasserson TJ, et al. A systematic review and meta-analysis: tailoring asthma treatment on eosinophilic markers (exhaled nitric oxide or sputum eosinophils). Thorax 2012;67(3):199-208
   PubMed Web of Science ®Google Scholar
• Hastie AT, Moore WC, Li H, et al. Biomarker surrogates do not accurately predict sputum eosinophil and neutrophil percentages in asthmatic subjects. J Allergy Clin Immunol 2013;132(1):72-80. e12
   PubMed Web of Science ®Google Scholar
• Halonen M, Barbee R, Lebowitz M, Burrows B. An epidemiological study of the interrelationships of total serum immunoglobulin E, allergy skin-test reactivity, and eosinophilia. J Allergy Clin Immunol 1982;69(2):221-8
   Google Scholar
• Sunyer J, Antó JM, Castellsagué J, et al. Total serum IgE is associated with asthma independently of specific IgE levels. Eur Respir J 1996;9(9):1880-4
   Google Scholar
• Simpson A, Soderstrom L, Ahlstedt S, et al. IgE antibody quantification and the probability of wheeze in preschool children. J Allergy Clin Immunol 2005;116(4):744-9
   PubMed Web of Science ®Google Scholar
• Baldacci S, Omenaas E, Oryszczyn MP. Allergy markers in respiratory epidemiology. Eur Respir J 2001;17(4):773-90
   PubMed Web of Science ®Google Scholar
• Tschopp JM, Sistek D, Schindler C, et al. Current allergic asthma and rhinitis: diagnostic efficiency of three commonly used atopic markers (IgE, skin prick tests, and Phadiatop). Results from 8329 randomized adults from the SAPALDIA study. Swiss study on air pollution and lung diseases in adults. Allergy 1998;53(6):608-13
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Boushey HA, Dolganov GM, et al. Genome-wide profiling identifies epithelial cell genes associated with asthma and with treatment response to corticosteroids. Proc Natl Acad Sci USA 2007;104(40):15858-63
   PubMed Web of Science ®Google Scholar
• Jia G, Erickson RW, Choy DF, et al. Periostin is a systemic biomarker of eosinophilic airway inflammation in asthmatic patients. J Allergy Clin Immunol 2012;130(3):647-54. e10
   PubMed Web of Science ®Google Scholar
• Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol 2006;133(5):468-92
   Google Scholar
• Horn BR, Robin ED, Theodore J, Van Kessel A. Total eosinophil counts in the management of bronchial asthma. N Engl J Medi 1975;92(22):1152-5
   Google Scholar
• Druilhe A, Létuvé S, Pretolani M. Glucocorticoid-induced apoptosis in human eosinophils: mechanisms of action. Apoptosis 2003;8(5):481-95
   PubMed Web of Science ®Google Scholar
• Massanari M, Holgate ST, Busse WW, et al. Effect of omalizumab on peripheral blood eosinophilia in allergic asthma. Respir Med 2010;104(2):188-96
   PubMed Web of Science ®Google Scholar
• Winkel P, Statland BE, Saunders AM, et al. Within-day physiologic variation of leukocyte types in healthy subjects as assayed by two automated leukocyte differential analyzers. Am J Clin Pathol 1981;75(5):693-700
   PubMed Web of Science ®Google Scholar
• Koh GC-H, Shek LP-C, Goh DY-T, et al. Eosinophil cationic protein: is it useful in asthma? A systematic review. Respir Med 2007;101(4):696-705
   PubMed Web of Science ®Google Scholar
• Venge P. Genomics and proteomics of the human eosinophil. In: James JL, Helen FR, editors. Eosinophils in health and disease. Elsevier; CA, USA: 2013. p. 432-42
   Google Scholar
• Tests of Eosinophilic Airway Inflammation. In: BTS/SIGN Guideline on the Management of Asthma. A national clinical guideline. UK. 2012; p. 26.
   Google Scholar
• Green RH, Brightling CE, McKenna S, et al. Asthma exacerbations and sputum eosinophil counts: a randomised controlled trial. Lancet 2002;360(9347):1715-21
   PubMed Web of Science ®Google Scholar
• Fleming L, Wilson N, Regamey N, Bush A. Use of sputum eosinophil counts to guide management in children with severe asthma. Thorax 2012;67(3):193-8
   PubMed Web of Science ®Google Scholar
• Woodruff PG, Khashayar R, Lazarus SC, et al. Relationship between airway inflammation, hyperresponsiveness, and obstruction in asthma. J Allergy Clin Immunol 2001;108(5):753-8
   PubMed Web of Science ®Google Scholar
• Lex C, Ferreira F, Zacharasiewicz A, et al. Airway eosinophilia in children with severe asthma: predictive values of noninvasive tests. Am J Respir Crit Care Med 2006;174(12):1286-91
   Web of Science ®Google Scholar
• Claman D, Boushey H, Liu J, et al. Analysis of induced sputum to examine the effects of prednisone on airway inflammation in asthmatic subjects. J Allergy Clin Immunol 1994;94(5):861-9
   Google Scholar
• Meyer KC, Raghu G, Baughman RP, et al. An official American Thoracic Society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med 2012;185(9):1004-14
   PubMed Web of Science ®Google Scholar
• Wardlaw AJ, Dunnette S, Gleich GJ, et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1998;137(1):62-9
   Google Scholar
• Walker C, Kaegi M, Braun P, Blaser K. Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity. J Allergy Clin Immunol 1991;88(6):935-42
   PubMedGoogle Scholar
• Costabel U, Teschler H, Guzman J. Bronchiolitis obliterans organizing pneumonia (BOOP): the cytological and immunocytological profile of bronchoalveolar lavage. Eur Respir J 1992;5(7):791-7
   Web of Science ®Google Scholar
• Allen JN, Davis WB, Pacht ER. Diagnostic significance of increased bronchoalveolar lavage fluid eosinophils. Am Rev Respir Dis 1990;142(3):642-7
   Google Scholar
• Persson CG, Uller L. Resolution of cell-mediated airways diseases. Respir Res 2010;11(1):75
   Google Scholar
• Rand IA Du, Blaikly J, Booton R, et al. British Thoracic Society Guideline for diagnostic flexible bronchoscopy in adults. Thorax 2013;68:i1-i44
   PubMed Web of Science ®Google Scholar
• Kim C-K, Callaway Z, Fletcher R, Koh YY. Eosinophil-derived neurotoxin in childhood asthma: correlation with disease severity. J Asthma 2010;47(5):568-73
   PubMed Web of Science ®Google Scholar
• Sorrentino S, Glitz DG, Hamann KJ, et al. Eosinophil-derived neurotoxin and human liver ribonuclease. Identity of structure and linkage of neurotoxicity to nuclease activity. J Biol Chem 1992;267(21):14859-65
   Google Scholar
• Kulkarni NS, Hollins F, Sutcliffe A, et al. Eosinophil protein in airway macrophages: a novel biomarker of eosinophilic inflammation in patients with asthma. J Allergy Clin Immunol 2010;126(1):61-9.e3
   Google Scholar
• Castro M, Fain SB, Hoffman EA, et al. Lung imaging in asthmatic patients: the picture is clearer. J Allergy Clin Immunol 2011;128(3):467-78
   Google Scholar
• Harris RS, Venegas JG, Wongviriyawong C, et al. 18F-FDG uptake rate is a biomarker of eosinophilic inflammation and airway response in asthma. J Nucl Med 2011;52(11):1713-20
   PubMed Web of Science ®Google Scholar
• Hansel TT, De Vries IJ, Iff T, et al. An improved immunomagnetic procedure for the isolation of highly purified human blood eosinophils. J Immunol Methods 1991;145(1-2):105-10
   Google Scholar
• Peters a M. Imaging inflammation: current role of labeled autologous leukocytes. J Nucl Med 1992;33(1):65-7
   Google Scholar
• Ruparelia P, Szczepura KR, Summers C, et al. Quantification of neutrophil migration into the lungs of patients with chronic obstructive pulmonary disease. Eur J Nucl Med Mol Imaging 2011;38(5):911-19
   Google Scholar
• Farahi N, Loutsios C, Peters AM, et al. Use of 99m Technetium-labeled eosinophils to detect active eosinophilic inflammation in man. Am J Respir Crit Care Med 2013;188(7):880-2
   Google Scholar
• Chrystalla L, Neda F, Charlotte S, et al. Use of radiolabelled leukocytes for drug evaluation in man. In: Moyer BR, Cheruvu NPS, Hu T, editors. Pharmaco-imaging in drug and biologics development. Springer; NY, USA: 2014. p. 215-47
   Google Scholar